Trial Profile
Phase I Study of ET-743 in Pediatric Refractory Solid Tumors
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Trabectedin (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 23 Sep 2005 New trial record.